← signals
2026-08-13·INTC·partnership
lowup

Manifold's market page shows a 96.54% consensus that Tesla will announce a formal Intel partnership for an AI chip fab...

Manifold's market page shows a 96.54% consensus that Tesla will announce a formal Intel partnership for an AI chip fab by June 30, 2026.

window 45devidence 4confidence score 91price INTC $97.52

confidence score

Strong evidence: 1 independent source class support this read.

91
low confidence1 independent source classesmarketpasses publish gate
priced-in check

INTC has not made a large direction-matching 30-90 day move yet.

not priced in
as of 2026-08-107d n/a45d n/a90d -19%yahoo

signal brief

Manifold's market page shows a 96.54% consensus that Tesla will announce a formal Intel partnership for an AI chip fab by June 30, 2026. If realized, this would be a major foundry design win for Intel, giving it a marquee AI silicon customer and a domestic advanced-node manufacturing anchor. It would directly compete with TSMC's role for Tesla's Dojo AI chips and strengthen Intel's foundry pipeline. The same event feed shows 48.73% odds of a TSMC-Intel joint venture and 27% odds that Intel will manufacture NVIDIA chips, indicating the market is pricing multiple paths to Intel foundry recovery rather than just Tesla. However, the market is a single, uncorroborated source and the exact chip, process node, wafer volume, and timeline are unstated. Direction: up for INTC's foundry competitiveness; spillover: TSM as the incumbent manufacturer, NVDA as part of the AI accelerator competitive set. Confidence: low. Expected impact window: 30-60 days.

What the sources said:

  • "Manifold consensus on 'Tesla announces formal Intel partnership for AI chip fab by June 30, 2026': YES=96.54%" (source)
  • "Manifold consensus on 'Will there be a joint venture chip foundry between TSMC and Intel?': YES=48.73%" (source)
  • "Manifold consensus on 'Will Intel manufacture NVIDIA chips by the end of 2026?': YES=27.00%" (source)

source data used

spillover entities

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.